Logo (1)
U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Appoints New Members to Its Advisory Board, Amid Rapid Growth in Psychedelic Sector
November 08, 2021 08:37 ET | Palo Santo
CHICAGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Palo Santo, the leading U.S.–based psychedelic investment fund, announced its advisory board, which includes some of the world’s foremost leaders in their...
Palo Santo is a U.S.-based psychedelic investment fund focused on increasing the supply of clinically effective and accessible mental health and addiction treatment solutions needed in today’s world.
U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Announces Recent Investment in neurocare Group
September 21, 2021 08:51 ET | Palo Santo
CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Palo Santo, a U.S.-based psychedelic investment fund, announced its recent investment in neurocare Group AG (“neurocare”), a leading provider of...